栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/01/31 | 2,442.5 | 2,492.5 | 2,422.5 | 2,425 | +5 | +0.2% | 273,000 |
2018/01/30 | 2,427.5 | 2,460 | 2,400 | 2,420 | -17.5 | -0.7% | 309,800 |
2018/01/29 | 2,450 | 2,590 | 2,402.5 | 2,437.5 | -25 | -1% | 1,157,800 |
2018/01/26 | 2,495 | 2,505 | 2,447.5 | 2,462.5 | -57.5 | -2.3% | 352,000 |
2018/01/25 | 2,545 | 2,550 | 2,505 | 2,520 | -20 | -0.8% | 136,400 |
2018/01/24 | 2,595 | 2,600 | 2,530 | 2,540 | -35 | -1.4% | 239,200 |
2018/01/23 | 2,600 | 2,620 | 2,575 | 2,575 | -10 | -0.4% | 167,200 |
2018/01/22 | 2,615 | 2,615 | 2,565 | 2,585 | -30 | -1.1% | 126,400 |
2018/01/19 | 2,570 | 2,625 | 2,565 | 2,615 | +60 | +2.3% | 184,000 |
2018/01/18 | 2,570 | 2,580 | 2,545 | 2,555 | +5 | +0.2% | 151,000 |
2018/01/17 | 2,540 | 2,565 | 2,540 | 2,550 | -5 | -0.2% | 96,200 |
2018/01/16 | 2,585 | 2,600 | 2,545 | 2,555 | -15 | -0.6% | 176,600 |
2018/01/15 | 2,580 | 2,590 | 2,565 | 2,570 | ±0 | ±0% | 121,400 |
2018/01/12 | 2,565 | 2,605 | 2,550 | 2,570 | -20 | -0.8% | 418,000 |
2018/01/11 | 2,660 | 2,675 | 2,580 | 2,590 | -105 | -3.9% | 262,000 |
2018/01/10 | 2,750 | 2,750 | 2,685 | 2,695 | -65 | -2.4% | 154,800 |
2018/01/09 | 2,745 | 2,805 | 2,740 | 2,760 | +15 | +0.5% | 135,400 |
2018/01/05 | 2,750 | 2,760 | 2,715 | 2,745 | +5 | +0.2% | 91,800 |
2018/01/04 | 2,725 | 2,755 | 2,725 | 2,740 | +40 | +1.5% | 85,600 |
2017/12/29 | 2,715 | 2,725 | 2,690 | 2,700 | -5 | -0.2% | 64,400 |
2017/12/28 | 2,740 | 2,770 | 2,700 | 2,705 | -55 | -2% | 80,800 |
2017/12/27 | 2,690 | 2,760 | 2,685 | 2,760 | +60 | +2.2% | 100,800 |
2017/12/26 | 2,715 | 2,760 | 2,695 | 2,700 | -15 | -0.6% | 95,200 |
2017/12/25 | 2,655 | 2,720 | 2,635 | 2,715 | +65 | +2.5% | 122,000 |
2017/12/22 | 2,620 | 2,655 | 2,615 | 2,650 | +10 | +0.4% | 82,800 |
2017/12/21 | 2,615 | 2,645 | 2,605 | 2,640 | +20 | +0.8% | 82,600 |
2017/12/20 | 2,590 | 2,625 | 2,585 | 2,620 | +20 | +0.8% | 96,600 |
2017/12/19 | 2,620 | 2,640 | 2,600 | 2,600 | -50 | -1.9% | 94,800 |
2017/12/18 | 2,635 | 2,675 | 2,625 | 2,650 | +35 | +1.3% | 217,000 |
2017/12/15 | 2,620 | 2,645 | 2,605 | 2,615 | -15 | -0.6% | 127,200 |
2017/12/14 | 2,640 | 2,660 | 2,605 | 2,630 | +25 | +1% | 145,000 |
2017/12/13 | 2,635 | 2,635 | 2,590 | 2,605 | -35 | -1.3% | 193,200 |
2017/12/12 | 2,650 | 2,670 | 2,625 | 2,640 | -10 | -0.4% | 93,600 |
2017/12/11 | 2,690 | 2,690 | 2,640 | 2,650 | +10 | +0.4% | 109,800 |
2017/12/08 | 2,615 | 2,655 | 2,600 | 2,640 | +35 | +1.3% | 146,400 |
2017/12/07 | 2,565 | 2,630 | 2,535 | 2,605 | +65 | +2.6% | 246,200 |
2017/12/06 | 2,525 | 2,600 | 2,497.5 | 2,540 | +20 | +0.8% | 246,400 |
2017/12/05 | 2,545 | 2,565 | 2,485 | 2,520 | -50 | -1.9% | 355,800 |
2017/12/04 | 2,625 | 2,625 | 2,550 | 2,570 | -40 | -1.5% | 149,200 |
2017/12/01 | 2,575 | 2,625 | 2,570 | 2,610 | +35 | +1.4% | 259,600 |
2017/11/30 | 2,467.5 | 2,575 | 2,460 | 2,575 | +77.5 | +3.1% | 268,400 |
2017/11/29 | 2,432.5 | 2,497.5 | 2,417.5 | 2,497.5 | +60 | +2.5% | 208,400 |
2017/11/28 | 2,390 | 2,447.5 | 2,362.5 | 2,437.5 | +67.5 | +2.8% | 205,400 |
2017/11/27 | 2,390 | 2,397.5 | 2,362.5 | 2,370 | -20 | -0.8% | 113,400 |
2017/11/24 | 2,360 | 2,397.5 | 2,340 | 2,390 | +27.5 | +1.2% | 103,000 |
2017/11/22 | 2,357.5 | 2,377.5 | 2,345 | 2,362.5 | +5 | +0.2% | 114,600 |
2017/11/21 | 2,352.5 | 2,375 | 2,335 | 2,357.5 | +5 | +0.2% | 143,800 |
2017/11/20 | 2,345 | 2,372.5 | 2,335 | 2,352.5 | +7.5 | +0.3% | 144,600 |
2017/11/17 | 2,330 | 2,370 | 2,310 | 2,345 | +37.5 | +1.6% | 280,600 |
2017/11/16 | 2,250 | 2,327.5 | 2,247.5 | 2,307.5 | +37.5 | +1.7% | 236,000 |
1651~
1700
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム